The $AUBRAI token, launched by BioProtocol on the Base blockchain, has experienced rapid trading activity and substantial price appreciation since its debut. The token's market capitalization surged from approximately $350,000 to $18 million shortly after launch, representing a nearly 20-fold increase for early participants. The total supply is capped at 2 million tokens, resulting in a fully diluted valuation of around $23 million. The launch event saw participation from over 2,000 wallets globally and was oversubscribed 14 times, generating $3.5 million in trading volume within 20 minutes. Additionally, $45,000 in research funding was secured in under an hour through more than $6 million in trading volume. The project includes the creation of the first BioAgent, a digital twin of Aubrey de Grey, a noted figure in biogerontology. Enthusiasts and participants have expressed ambitions to increase the token's fully diluted valuation to $100 million.